Pasithea Therapeutics Corp.
Hedge Funds Holdings

Last updated:

Pasithea Therapeutics Corp.‘s stocks are currently a part of 6 hedge funds’ portfolios, which represents 0.24% of the total amount of its stocks outstanding. This makes up a total of 61.60K shares of Pasithea Therapeutics Corp.. Compared to the previous quarter, the number fell by -90.24% or -569.79K shares fewer. As for the holding position changes, 16.67% (1) of current hedge fund investors increased the number of shares held, 50% (3) of current holders sold a part of the shares held, and 33.33% (2) closed the holdings completely. 1 hedge funds are new holders of Pasithea Therapeutics Corp. stock in Q1 2023, it is 16.67% of total holders.

Hedge funds holding Pasithea Therapeutics Corp. (Q3 2021 – Q1 2023)

Number of hedge funds
Q3 2021 4
Q4 2021 6
Q1 2022 7
Q2 2022 8
Q3 2022 8
Q4 2022 11
Q1 2023 6

Hedge funds changes in Pasithea Therapeutics Corp. positions (Q3 2021 – Q1 2023)

Changes in positions
Q3 2021 40000
Q4 2021 5103-3
Q1 2022 32020
Q2 2022 5114-3
Q3 2022 13112
Q4 2022 44210
Q1 2023 1132-1

Top 50 hedge fund holders of Pasithea Therapeutics Corp. (NASDAQ:KTTA)

Hedge fund Value Shares owned Portfolio share
K2 PRINCIPAL FUND, L.P. 620K 491.79K 0.071%
VANGUARD GROUP INC 201K 159.84K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 124K 98.59K 0.000%
OLD WELL PARTNERS, LLC 42K 33K 0.035%
STATE STREET CORP 30K 23.64K 0.000%
UBS GROUP AG 7K 5.45K 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 7K 5.65K 0.000%
JPMORGAN CHASE & CO 1K 1K 0.000%
VIRTU FINANCIAL LLC 0 0 0.000%